← Database
Eugeroic (Wakefulness)

Fladrafinil

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

A bisfluoro analog in the adrafinil/modafinil family marketed for wakefulness; human clinical data are minimal.

How it works

Fladrafinil is a chemical relative of the wakefulness drug modafinil (specifically a fluorinated analog), marketed for alertness and focus.

It's believed to share modafinil's basic mechanism — a weak blockade of the dopamine transporter that raises extracellular dopamine and promotes wakefulness — although its specific pharmacology has been poorly characterized.

Human safety and efficacy data are minimal, and it is not an approved medication; it sits in the gray market as a modafinil-like research chemical.

Mechanism · Detailed Analysis
Molecular targetA modafinil-family eugeroic (a bisfluoro analogue of adrafinil/modafinil).
Proposed downstream effectsBelieved to share modafinil’s mechanism — weak dopamine-transporter inhibition raising extracellular dopamine and promoting wakefulness.
CaveatsSpecific clinical pharmacology is poorly characterised; minimal human data; not approved.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.